157 related articles for article (PubMed ID: 21474590)
1. Interleukin 10 deficiency attenuates induction of anti-TSH receptor antibodies and hyperthyroidism in a mouse Graves' model.
Ueki I; Abiru N; Kawagoe K; Nagayama Y
J Endocrinol; 2011 Jun; 209(3):353-7. PubMed ID: 21474590
[TBL] [Abstract][Full Text] [Related]
2. TSH receptor-adenovirus-induced Graves' hyperthyroidism is attenuated in both interferon-gamma and interleukin-4 knockout mice; implications for the Th1/Th2 paradigm.
Nagayama Y; Saitoh O; McLachlan SM; Rapoport B; Kano H; Kumazawa Y
Clin Exp Immunol; 2004 Dec; 138(3):417-22. PubMed ID: 15544617
[TBL] [Abstract][Full Text] [Related]
3. Adenovirus encoding the thyrotropin receptor A-subunit improves the efficacy of dendritic cell-induced Graves' hyperthyroidism in mice.
Mizutori Y; Saitoh O; Eguchi K; Nagayama Y
J Autoimmun; 2006 Feb; 26(1):32-6. PubMed ID: 16242303
[TBL] [Abstract][Full Text] [Related]
4. Distinct role of T helper Type 17 immune response for Graves' hyperthyroidism in mice with different genetic backgrounds.
Horie I; Abiru N; Saitoh O; Ichikawa T; Iwakura Y; Eguchi K; Nagayama Y
Autoimmunity; 2011 Mar; 44(2):159-65. PubMed ID: 20670120
[TBL] [Abstract][Full Text] [Related]
5. Thyrotropin Receptor-Specific Lymphocytes in Adenovirus-TSHR-Immunized Native and Human Leukocyte Antigen-DR3-Transgenic Mice and in Graves' Disease Patient Blood.
Degen H; Gavvovidis I; Blankenstein T; Uhland K; Ungerer M
Thyroid; 2021 Jun; 31(6):950-963. PubMed ID: 33208049
[No Abstract] [Full Text] [Related]
6. Adenovirus-mediated gene delivery of interleukin-10, but not transforming growth factor beta, ameliorates the induction of Graves' hyperthyroidism in BALB/c mice.
Saitoh O; Mizutori Y; Takamura N; Yamasaki H; Kita A; Kuwahara H; Nagayama Y
Clin Exp Immunol; 2005 Sep; 141(3):405-11. PubMed ID: 16045729
[TBL] [Abstract][Full Text] [Related]
7. CD8+CD122+ T cells, a newly identified regulatory T subset, negatively regulate Graves' hyperthyroidism in a murine model.
Saitoh O; Abiru N; Nakahara M; Nagayama Y
Endocrinology; 2007 Dec; 148(12):6040-6. PubMed ID: 17823258
[TBL] [Abstract][Full Text] [Related]
8. Dendritic cells infected with adenovirus expressing the thyrotrophin receptor induce Graves' hyperthyroidism in BALB/c mice.
Kita-Furuyama M; Nagayama Y; Pichurin P; McLachlan SM; Rapoport B; Eguchi K
Clin Exp Immunol; 2003 Feb; 131(2):234-40. PubMed ID: 12562382
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility rather than resistance to hyperthyroidism is dominant in a thyrotropin receptor adenovirus-induced animal model of Graves' disease as revealed by BALB/c-C57BL/6 hybrid mice.
Chen CR; Aliesky H; Pichurin PN; Nagayama Y; McLachlan SM; Rapoport B
Endocrinology; 2004 Nov; 145(11):4927-33. PubMed ID: 15284197
[TBL] [Abstract][Full Text] [Related]
10. Schistosoma mansoni and alpha-galactosylceramide: prophylactic effect of Th1 Immune suppression in a mouse model of Graves' hyperthyroidism.
Nagayama Y; Watanabe K; Niwa M; McLachlan SM; Rapoport B
J Immunol; 2004 Aug; 173(3):2167-73. PubMed ID: 15265954
[TBL] [Abstract][Full Text] [Related]
11. Regulation of Graves' hyperthyroidism with naturally occurring CD4+CD25+ regulatory T cells in a mouse model.
Saitoh O; Nagayama Y
Endocrinology; 2006 May; 147(5):2417-22. PubMed ID: 16439459
[TBL] [Abstract][Full Text] [Related]
12. Thyrotrophin receptor-specific memory T cell responses require normal B cells in a murine model of Graves' disease.
Pichurin P; Aliesky H; Chen CR; Nagayama Y; Rapoport B; McLachlan SM
Clin Exp Immunol; 2003 Dec; 134(3):396-402. PubMed ID: 14632743
[TBL] [Abstract][Full Text] [Related]
13. TSH-receptor autoantibodies - differentiation of hyperthyroidism between Graves' disease and toxic multinodular goitre.
Wallaschofski H; Kuwert T; Lohmann T
Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):171-4. PubMed ID: 15127319
[TBL] [Abstract][Full Text] [Related]
14. B cell-targeted therapy with anti-CD20 monoclonal antibody in a mouse model of Graves' hyperthyroidism.
Ueki I; Abiru N; Kobayashi M; Nakahara M; Ichikawa T; Eguchi K; Nagayama Y
Clin Exp Immunol; 2011 Mar; 163(3):309-17. PubMed ID: 21235532
[TBL] [Abstract][Full Text] [Related]
15. Insight into Graves' hyperthyroidism from animal models.
McLachlan SM; Nagayama Y; Rapoport B
Endocr Rev; 2005 Oct; 26(6):800-32. PubMed ID: 15827111
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of experimental Graves' disease by intranasal administration of a T cell epitope of the thyrotropin receptor.
Arima T; Shimojo N; Yamaguchi K; Tomiita M; Kohn LD; Kohno Y
Clin Immunol; 2008 Apr; 127(1):7-13. PubMed ID: 18234558
[TBL] [Abstract][Full Text] [Related]
17. Exceptional hyperthyroidism and a role for both major histocompatibility class I and class II genes in a murine model of Graves' disease.
McLachlan SM; Aliesky HA; Chen CR; Williams RW; Rapoport B
PLoS One; 2011; 6(6):e21378. PubMed ID: 21738647
[TBL] [Abstract][Full Text] [Related]
18. Prevention of autoantibody-mediated Graves'-like hyperthyroidism in mice with IL-4, a Th2 cytokine.
Nagayama Y; Mizuguchi H; Hayakawa T; Niwa M; McLachlan SM; Rapoport B
J Immunol; 2003 Apr; 170(7):3522-7. PubMed ID: 12646613
[TBL] [Abstract][Full Text] [Related]
19. Graves' animal models of Graves' hyperthyroidism.
Nagayama Y
Thyroid; 2007 Oct; 17(10):981-8. PubMed ID: 17822377
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D deficiency modulates Graves' hyperthyroidism induced in BALB/c mice by thyrotropin receptor immunization.
Misharin A; Hewison M; Chen CR; Lagishetty V; Aliesky HA; Mizutori Y; Rapoport B; McLachlan SM
Endocrinology; 2009 Feb; 150(2):1051-60. PubMed ID: 18927213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
